264 related articles for article (PubMed ID: 27622063)
1. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death.
Di Blasio S; Wortel IM; van Bladel DA; de Vries LE; Duiveman-de Boer T; Worah K; de Haas N; Buschow SI; de Vries IJ; Figdor CG; Hato SV
Oncoimmunology; 2016 Aug; 5(8):e1192739. PubMed ID: 27622063
[TBL] [Abstract][Full Text] [Related]
2. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
[TBL] [Abstract][Full Text] [Related]
3. Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
Fucikova J; Kralikova P; Fialova A; Brtnicky T; Rob L; Bartunkova J; Spísek R
Cancer Res; 2011 Jul; 71(14):4821-33. PubMed ID: 21602432
[TBL] [Abstract][Full Text] [Related]
4. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
[TBL] [Abstract][Full Text] [Related]
5. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Miyazaki M; Ikeda S; Tsumura H
Oncol Lett; 2016 Mar; 11(3):2169-2175. PubMed ID: 26998143
[TBL] [Abstract][Full Text] [Related]
7. Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.
Flieswasser T; Van Loenhout J; Freire Boullosa L; Van den Eynde A; De Waele J; Van Audenaerde J; Lardon F; Smits E; Pauwels P; Jacobs J
Cells; 2020 Jun; 9(6):. PubMed ID: 32560232
[TBL] [Abstract][Full Text] [Related]
8. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
Rodríguez-Salazar MDC; Franco-Molina MA; Mendoza-Gamboa E; Martínez-Torres AC; Zapata-Benavides P; López-González JS; Coronado-Cerda EE; Alcocer-González JM; Tamez-Guerra RS; Rodríguez-Padilla C
Oncol Lett; 2017 Jul; 14(1):844-852. PubMed ID: 28693241
[TBL] [Abstract][Full Text] [Related]
9. Capsaicin induces immunogenic cell death in human osteosarcoma cells.
Jin T; Wu H; Wang Y; Peng H
Exp Ther Med; 2016 Aug; 12(2):765-770. PubMed ID: 27446273
[TBL] [Abstract][Full Text] [Related]
10. CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice.
Sakakibara K; Sato T; Kufe DW; VonHoff DD; Kawabe T
Oncotarget; 2017 Oct; 8(45):78277-78288. PubMed ID: 29108228
[TBL] [Abstract][Full Text] [Related]
11. Induction of immunogenic cell death by chemotherapeutic platinum complexes.
Wong DY; Ong WW; Ang WH
Angew Chem Int Ed Engl; 2015 May; 54(22):6483-7. PubMed ID: 25873535
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F
Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929
[TBL] [Abstract][Full Text] [Related]
14. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
15. Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.
Adkins I; Sadilkova L; Hradilova N; Tomala J; Kovar M; Spisek R
Oncoimmunology; 2017; 6(5):e1311433. PubMed ID: 28638734
[TBL] [Abstract][Full Text] [Related]
16. Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy.
Jafari S; Heydarian S; Lai R; Mehdizadeh Aghdam E; Molavi O
Bioimpacts; 2023; 13(1):51-61. PubMed ID: 36816998
[No Abstract] [Full Text] [Related]
17. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
[TBL] [Abstract][Full Text] [Related]
18. Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.
van Beek JJ; Gorris MA; Sköld AE; Hatipoglu I; Van Acker HH; Smits EL; de Vries IJ; Bakdash G
Oncoimmunology; 2016; 5(10):e1227902. PubMed ID: 27853652
[TBL] [Abstract][Full Text] [Related]
19. Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade.
Kofla G; Radecke C; Frentsch M; Walther W; Stintzing S; Riess H; Bullinger L; Na IK
Oncoimmunology; 2022; 11(1):2068109. PubMed ID: 35496500
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
